Exhibit 3.1
FOURTH AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
LOGICBIO THERAPEUTICS, INC.
LogicBio Therapeutics, Inc., a Delaware corporation (the “Corporation”), hereby certifies that this Fourth Amended and Restated Certificate of Incorporation has been duly adopted by the stockholders of the Corporation (by written consent pursuant to Section 228 of the General Corporation Law of the State of Delaware) in accordance with Sections 242 and 245 of the General Corporation Law of the State of Delaware, and that:
A. The name of the Corporation is: LogicBio Therapeutics, Inc.
B. The Corporation filed its Certificate of Incorporation with the Secretary of State of the State of Delaware on August 4, 2014. The Certificate of Incorporation was amended and restated by each of the Amended and Restated Certificate of Incorporation filed on January 6, 2016, the Amended and Restated Certificate of Incorporation filed on June 19, 2017 and the Amended and Restated Certificate of Incorporation filed on June 25, 2018, and was amended by the Certificate of Amendment filed on October 8, 2018 (the “Original Certificate of Incorporation”).
C. This Fourth Amended and Restated Certificate of Incorporation amends and restates the Original Certificate of Incorporation of the Corporation.
D. The Certificate of Incorporation upon the filing of this Fourth Amended and Restated Certificate of Incorporation, shall read as follows:
ARTICLE I — NAME
The name of the corporation is LogicBio Therapeutics, Inc. (the “Corporation”).
ARTICLE II — REGISTERED OFFICE AND AGENT
The address of the Corporation’s registered office in the State of Delaware is located at Corporation Trust Center, 1209 Orange Street, in the City of Wilmington, County of New Castle 19801. The name of its registered agent at such address is The Corporation Trust Company.
ARTICLE III — PURPOSE
The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware (the “DGCL”).
ARTICLE IV — CAPITALIZATION
(a)Authorized Shares. The total number of shares of stock which the Corporation shall have authority to issue is 200,000,000, consisting of 175,000,000 shares of Common Stock, par value $0.0001 per share (“Common Stock”), and 25,000,000 shares of Preferred Stock, par value $0.0001 per share (“Preferred Stock”). Such stock may be issued from time to time by the Corporation for such consideration as may be fixed by the board of directors of the Corporation (the “Board of Directors”).
(b)Common Stock. Subject to the powers, preferences and rights of any Preferred Stock, including any series thereof, having any preference or priority over, or rights superior to, the Common Stock and except as otherwise provided by law and this Article IV, the holders of the Common Stock shall have and possess all powers and voting and other rights pertaining to the stock of the Corporation.
(i)Voting. Each holder of Common Stock shall be entitled to one vote for each share of Common Stock held of record by such holder on all matters on which stockholders generally are entitled to vote;provided, that, except as otherwise required by law, holders of Common Stock shall have no voting power with respect to, and shall not